; (C) may include relevant facts and circumstances relating to— (i) public health agencies; (ii) health care agencies; (iii) financial and labor agencies; (iv) intelligence agencies; (v) defense and national security agencies; (vi) diplomacy and development agencies; (vii) White House offices and councils; (viii) private sector organizations; (ix) scientific research; (x) pandemic preparedness and response; (xi) vaccine, diagnostic, and therapeutics research and development; (xii) underserved populations, older adults, and all populations facing health disparities; (xiii) immigration and border control; (xiv) international trade and supply chains; (xv) the role of congressional and State government oversight and resource allocation; and (xvi) other areas of the public and private sectors determined relevant by the Commission for its inquiry; (2) identify, review, and evaluate the lessons learned from the COVID–19 pandemic regarding the structure, coordination, management policies, and procedures of the Federal Government and State, local, Tribal, and territorial governments and nongovernmental entities, relative to detecting, preventing, and responding to epidemics and pandemics, whether naturally occurring or caused by State or non-State actors; and (3) submit to the President and Congress such reports as are required by this Act containing such findings, conclusions, and legislative, regulatory, and policy recommendations as the Commission shall determine, including proposing organization, coordination, planning, management arrangements, procedures, rules, and regulations. 6. Powers of the Commission (a) In general (1) Hearings and evidence The Commission or, on the authority of the Commission, any subcommittee or member thereof, may, for the purpose of carrying out this Act— (A) hold such hearings, sit and act at such times and places, take such testimony, receive such evidence, and administer such oaths as the Commission or such designated subcommittee or designated member may determine advisable